Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
This important study is looking at a new pill form of a medicine called cladribine for people who have generalized myasthenia gravis. Myasthenia gravis is a condition that causes muscles to weaken. The main goal is to find out if this new cladribine pill works better than a dummy pill (placebo) to improve symptoms, and if it's safe to use. Researchers are also interested in understanding if the positive effects of the medicine last over time, if people might need to take it again, and what the long-term safety looks like. We'll also be studying how the body handles this new medicine. The study involves different stages, including a period where some people get the cladribine and others get a placebo, followed by longer-term follow-up periods. Some participants will also be asked about their experiences with the treatment and the study.
En un coup d'œil
De quoi parle cette étude ?
This research study, called MyClad, is focused on a health condition called generalized myasthenia gravis (gMG). If you have gMG, your muscles can become weak and tired, which can affect things like your eyes, face, throat, and limbs. Researchers are testing a new version of a medicine called cladribine, which comes as a pill. They want to find out two main things: first, if this new pill helps to improve the symptoms of gMG more effectively than a dummy pill (placebo), and second, if it's generally safe for people to take.
Beyond just looking at how well it works and its safety in the short term, the study also aims to understand the longer-term picture. This includes seeing if the positive effects of cladribine continue over time, whether people might need to take the medicine again later on, and how safe it is when used for a longer period. There's also a part of the study that looks at how your body processes and uses this new cladribine pill. This helps scientists understand the medicine better.
The study is set up in a few parts. Initially, some people will receive the cladribine pill, while others will receive a placebo. Neither you nor your doctor will know which one you are getting. After this initial period, there will be longer follow-up phases to continue observing the medicine's effects. Additionally, a small group of participants will be invited for interviews to share their personal experiences with the treatment and what it's like to be part of the study. This helps researchers understand the human side of the treatment.
Points clés
- This study is testing a new pill for generalized myasthenia gravis.
- It aims to see if the medicine, cladribine, is safe and effective compared to a dummy pill.
- Researchers are also looking at long-term benefits and how the medicine works in your body.
- Participation involves taking medication, regular check-ups, and potentially sharing experiences.
- You might receive the active medicine or a placebo, and neither you nor your doctor will know which during the initial phase.
Qui peut être éligible ?
To join this study, you must be at least 18 years old and have been diagnosed with generalized myasthenia gravis, where your muscles throughout your body are affected. This diagnosis needs to fit certain medical classifications, and your myasthenia gravis should involve general muscle weakness, not just in your eyes.
You'll also need certain symptom scores for myasthenia gravis that show your condition is stable and within a specific range, with a good portion of your symptoms not being just eye-related. If you're currently taking certain medications like steroids or medicines for myasthenia gravis (like pyridostigmine), you need to have been on a steady dose for at least three months, and those doses must be below a certain level. You also need to weigh at least 40 kilograms.
However, there are reasons you might not be able to join. For example, if you have other immune system conditions besides myasthenia gravis, or if you need to take steroid medicines for a long time for another health issue (except for a well-managed thyroid condition), you might not be eligible. The study also has other specific criteria that your doctor will review to make sure it's the right fit for you.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Avez-vous 18 ans ou plus ?
- Have you been diagnosed with generalized myasthenia gravis (not just eye symptoms)?
- Are your myasthenia gravis symptoms stable (not getting much worse or better suddenly)?
- If you take steroids or other MG medications, have you been on a steady dose for 3 months, and is that dose within specific limits?
- Do you weigh at least 40 kilograms?
En quoi consiste la participation ?
If you decide to join this study, you will go through different periods. Initially, you'll be in the 'double-blind' phase, meaning neither you nor your study doctor will know if you're receiving the new cladribine medication or a dummy pill (placebo). This helps make sure the study results are fair. This main part of the study will involve regular visits to the clinic, where you'll have check-ups, answer questions about your symptoms, and have blood tests. You will be taking the study medication, which is a pill, according to a specific schedule.
After this initial period, there will be further extension periods where the study continues, and more long-term effects are monitored. You might have continued clinic visits and assessments, and some participants might have the opportunity to receive cladribine if they were initially on the placebo. The study will look at your progress, how your symptoms change, and your general health over time. There will also be a focus on understanding how your body handles the medicine through specific tests (pharmacokinetics). Some participants will also be asked to share their experiences in interviews. The total duration of your involvement could be several years, given the focus on long-term safety and effectiveness.
Risques et avantages potentiels
Locations (154)
- Arizona Neuroscience Research, LLCCode postal vérifiéPhoenix, États-Unis· Recrutement
- Advanced Neurosciences Research LLCCode postal vérifiéLongmont, United States· Actif, mais pas en recrutement
- University of Connecticut Health Center - Department of MedicineCode postal vérifiéFarmington, United States· Recrutement
- The George Washington University Medical Faculty Associates Foggy Bottom South PavilionCode postal vérifiéWashington D.C., États-Unis· Recrutement
- Neurology of Central Florida Research Center, LLCCode postal vérifiéAltamonte Springs, United States· Recrutement
- SFM Clinical Research, LLCCode postal vérifiéBoca Raton, United States· Recrutement
- University of Florida Health Science Center - 300120311Code postal vérifiéJacksonville, États-Unis· Recrutement
- Neurology Associates, P. A.Code postal vérifiéMaitland, United States· Recrutement
- University of South Florida - PARENT - PARENTCode postal vérifiéTampa, États-Unis· Recrutement
- University of Kansas Medical Center Research Institute, Inc. - 3901 Rainbow (MAIN)Code postal vérifiéKansas City, États-Unis· Recrutement
- UNC Hospitals - PARENTCode postal vérifiéChapel Hill, États-Unis· Recrutement
- Atrium Health Wake Forest BaptistCode postal vérifiéWinston-Salem, United States· Recrutement
Questions fréquentes
What is generalized myasthenia gravis (gMG)?
It's a condition where your immune system mistakenly attacks connections between your nerves and muscles, causing muscle weakness throughout your body.
What is cladribine?
Cladribine is a medication that affects your immune system, and in this study, it's being tested in a new pill form for gMG to see if it can help reduce muscle weakness.
Que signifie 'placebo' ?
A placebo is a dummy pill that looks like the active medicine but contains no active ingredients. It's used to fairly compare the new medicine's effects.
Will I know if I'm getting the actual medicine or the dummy pill?
No, during the main part of the study, neither you nor your doctor will know. This is called 'double-blind' and helps ensure the study results are unbiased.
Combien de temps vais-je participer à l'étude ?
The study involves different periods, including initial treatment and longer-term follow-up, which could mean you participate for several years to track long-term effects.
Comment en savoir plus
US Medical Information
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Intéressé à participer ?
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.